nitazoxanide has been researched along with Cytokine Release Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Gareeb, AI; Al-Kuraishy, HM; Batiha, GE; Elekhnawy, E | 1 |
| Kelleni, MT | 1 |
1 review(s) available for nitazoxanide and Cytokine Release Syndrome
| Article | Year |
|---|---|
Nitazoxanide and COVID-19: A review.
Topics: Acute Lung Injury; Antiviral Agents; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
1 other study(ies) available for nitazoxanide and Cytokine Release Syndrome
| Article | Year |
|---|---|
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Interferons; Interleukin-6; Nitro Compounds; Observational Studies as Topic; SARS-CoV-2; Thiazoles | 2022 |